demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID-19 severe or critically
COVID-19 severe or critically
ivermectin Galan Galan Camprubi Okumuş

1 studies excluded by filtering options 2

6368 Niaee (vs placebo), 2020 213excludedhigh risk of bias